LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases—A randomized, double-blind, placebo-controlled, multicenter, multinational, phase II trial.
C. C. Schimanski
Employment or Leadership Position - Merck KGaA (I)
Consultant or Advisory Role - Merck KGaA
Honoraria - Merck KGaA
P. R. Galle
No relevant relationships to disclose
H. Lang
No relevant relationships to disclose
M. Schoen
No relevant relationships to disclose
M. H. Moehler
Honoraria - Merck KGaA
Research Funding - Merck KGaA